Prognosis
CDC Panel Backs Pfizer Shot; Boosters Under Review: Virus Update
This article is for subscribers only.
We're tracking the latest on the coronavirus outbreak and the global response. Sign up here for our daily newsletter on what you need to know.
A panel of outside advisers to the U.S. Centers for Disease Control and Prevention voted unanimously to recommend the Pfizer Inc. vaccine, which gained regulatory approval last week. The advisers are now set to discuss booster shots.